U.S. markets closed

NovoCure Limited (NVCR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
135.06+4.84 (+3.72%)
At close: 4:00PM EST

135.00 -0.06 (-0.04%)
After hours: 5:16PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close130.22
Open130.00
Bid134.06 x 800
Ask135.05 x 1200
Day's Range127.75 - 135.23
52 Week Range53.40 - 140.89
Volume913,492
Avg. Volume1,268,847
Market Cap13.749B
Beta (5Y Monthly)1.24
PE Ratio (TTM)734.02
EPS (TTM)0.18
Earnings DateFeb 25, 2021 - Mar 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est126.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Is Inovio Pharmaceuticals a Buy?
    Motley Fool

    Is Inovio Pharmaceuticals a Buy?

    A potential coronavirus vaccine isn't the only promising pipeline candidate for this small-cap biotech.

  • Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference
    Business Wire

    Novocure to Participate in the Evercore ISI 2020 Virtual HealthCONx Conference

    Novocure will participate in the 3rd Annual Evercore ISI 2020 Virtual HealthCONx Conference on December 1 through December 2, 2020.

  • Why Novocure Stock Sank Today
    Motley Fool

    Why Novocure Stock Sank Today

    Shares of Novocure (NASDAQ: NVCR) were sinking 9.2% as of 3:30 p.m. on Tuesday. The oncology therapy company didn't announce any news, so why did the stock fall on a day when the overall market soared? The most likely reason is that some investors decided to lock in profits after Novocure's year-to-date gain of nearly 60% as of the market close on Monday.